ASHLEIGH GLASS: Open Payments
NPI 1992204317 · BALLWIN, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,228 in 54 payments from 18 companies in 2025. Trend: 2023 $994 · 2024 $716 · 2025 $1,228
Food & beverage: $1,228
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 12 | $266 |
| AstraZeneca Pharmaceuticals LP | 9 | $201 |
| Boston Scientific Corporation | 2 | $164 |
| Novo Nordisk Inc | 4 | $73 |
| Abbott Laboratories | 3 | $68 |
| Novartis Pharmaceuticals Corporation | 3 | $64 |
| Amgen Inc. | 4 | $57 |
| Otsuka America Pharmaceutical, Inc. | 2 | $50 |
| PFIZER INC. | 3 | $48 |
| Exact Sciences Corporation | 2 | $45 |
Products named: WATCHMAN FLX, MOUNJARO, AIRSUPRA, KISUNLA, BREZTRI, FREESTYLE LIBRE 3, LEQVIO, JARDIANCE.
Industry payments across MO — which companies pay providers there.
